We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$212M
AUM Growth
+$3.12M
Cap. Flow
-$9.87M
Cap. Flow %
-4.65%
Top 10 Hldgs %
55.99%
Holding
71
New
3
Increased
20
Reduced
42
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 1.71%
2 Technology 0.89%
3 Financials 0.33%
4 Industrials 0.22%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REET icon
51
iShares Global REIT ETF
REET
$5.05B
$354K 0.17%
13,261
+124
+0.9% +$3.14K
RPAR icon
52
RPAR Risk Parity ETF
RPAR
$574M
$333K 0.16%
16,161
-238
-1% -$4.72K
REGN icon
53
Regeneron Pharmaceuticals
REGN
$70.9B
$312K 0.15%
297
-31
-9% -$34.5K
TMO icon
54
Thermo Fisher Scientific
TMO
$198B
$267K 0.13%
430
-26
-6% -$15.4K
HYG icon
55
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$232K 0.11%
2,889
-2,086
-42% -$164K
MDT icon
56
Medtronic
MDT
$106B
$209K 0.1%
+2,323
New +$195K
EW icon
57
Edwards Lifesciences
EW
$49.4B
$207K 0.1%
+3,142
New +$228K
MREO
58
Mereo BioPharma
MREO
$49.5M
$139K 0.07%
33,800
-2,431
-7% -$10.1K
IMTX icon
59
Immatics
IMTX
$1.31B
$128K 0.06%
11,180
-807
-7% -$9.55K
ZURA icon
60
Zura Bio
ZURA
$518M
$125K 0.06%
30,810
-10,759
-26% -$40.2K
COGT icon
61
Cogent Biosciences
COGT
$6.68B
$108K 0.05%
10,021
-5,606
-36% -$54.6K
KRON
62
DELISTED
Kronos Bio
KRON
$91K 0.04%
90,998
-44,000
-33% -$48.7K
GERN icon
63
Geron
GERN
$924M
$83.9K 0.04%
18,491
-1,415
-7% -$6.43K
NKTX icon
64
Nkarta
NKTX
$186M
$79.8K 0.04%
17,646
+5,813
+49% +$33K
PSTX
65
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$79.7K 0.04%
27,855
-1,962
-7% -$6.07K
CTMX icon
66
CytomX Therapeutics
CTMX
$788M
$70.5K 0.03%
59,760
-4,305
-7% -$5.47K
ANNX icon
67
Annexon
ANNX
$950M
$62.1K 0.03%
10,483
-5,620
-35% -$33.3K
LONA
68
LeonaBio Inc
LONA
$67.8M
-4,660
Closed -$123K
IAGG icon
69
iShares Core International Aggregate Bond Fund
IAGG
$10.6B
-7,232
Closed -$361K
PM icon
70
Philip Morris
PM
$301B
-2,738
Closed -$278K
TVTX icon
71
Travere Therapeutics
TVTX
$5.27B
-13,317
Closed -$109K

Similar funds

Forefront Analytics's Q3 2024 Portfolio in Review

As of Q3 2024, Forefront Analytics held 71 positions worth $212M, up 1.5% from $209M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Forefront Analytics withdrew a net $9.87M in Q3 2024, closing 4 positions and reducing 42 holdings. Its most notable exit was iShares Core International Aggregate Bond Fund, an estimated $361K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.7% of assets, up from 1.5% a quarter earlier, followed by Technology and Financials.

Against the trend, Forefront Analytics opened a new position in Abbott worth $443K.

  • Forefront Analytics's largest Q3 2024 buy was Abbott: 3,883 shares worth $443K.
  • Forefront Analytics added most to Nuveen ESG Large-Cap Value ETF in Q3 2024, an estimated $265K increase.
  • Forefront Analytics's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.84M.
  • Forefront Analytics fully exited iShares Core International Aggregate Bond Fund in Q3 2024, selling an estimated $361K.
  • Forefront Analytics's ten largest holdings make up 56% of its $212M portfolio in Q3 2024.
  • Forefront Analytics opened 3 new positions and closed 4 in Q3 2024.
  • Forefront Analytics's portfolio value rose 1.5% quarter-over-quarter to $212M.

Based on Forefront Analytics's 13F filing for Q3 2024, filed 14 Nov 2024.